PROLOG: Obstetrics, Ninth Edition (Assessment & Critique)

by College of American, American College of Obstetricians & Gynecologists MD

Overview

PROLOG: Obstetrics 9th Edition is a comprehensive, evidence-based review of core topics in obstetrics, designed for obstetricians, gynecologists, and other healthcare providers preparing for board certification exams or seeking to assess and update their clinical knowledge in obstetrics. This self-directed learning tool features 12 chapters covering a wide range of topics, including pregnancy, labor and delivery, fetal development, obstetric complications, high-risk pregnancy, and more. Each chapter includes multiple-choice questions and detailed answers, allowing readers to assess their understanding of the material and review at their own pace. The content of PROLOG: Obstetrics 9th Edition is based on the latest research and clinical guidelines, ensuring that readers have access to the most up-to-date information in the field. This edition is accredited by the Accreditation Council for Continuing Medical Education (ACCME), allowing healthcare providers who use PROLOG to earn continuing medical education (CME) credits. Overall, PROLOG: Obstetrics 9th Edition is a valuable resource for medical students, residents, and practicing physicians seeking to deepen their knowledge and skills.

Product Details

ISBN-13:	9781948258661
Publisher:	ACOG
Publication date:	03/01/2023
Series:	Prolog
Pages:	344
Product dimensions:	8.50(w) x 10.25(h) x 0.90(d)

About the Author

Founded in 1951, ACOG is the premier professional membership organization for obstetrician–gynecologists. The College produces practice guidelines for health care professionals and educational materials for patients, provides practice management and career support, facilitates programs and initiatives to improve women’s health, and advocates for members and patients. 

Table of Contents

Counseling Evaluation of fetal death (8) Exercise in pregnancy (19) Migraine (64) Obesity in a pregnant patient (2) Peripartum cardiomyopathy (43) Preterm prelabor rupture of membranes (172– 175) Smoking cessation (36) Timing of classical cesarean birth (10) Epidemiology and Biostatistics Anticoagulation for use postpartum and during breastfeeding (24) Barriers to breastfeeding (4) Electronic fetal monitoring (44) Human immunodeficiency virus testing in a pregnant patient (13) Neonatal encephalopathy (71) Obstetric anesthesia (51) Perinatal survival (70) Teratogenic drugs (120– 124) Ethical and Legal Issues Informed consent and shared decision making (197– 200) Maternal levels of care (157– 161) Neonatal levels of care (14) Periviable birth (48) Substance use disorder (21) Vaginal birth after multiple cesarean births (40) Medical Management Anemia (73) Antepartum fetal surveillance (91) Anticoagulation (201– 204) Asthma medications (27) Brachial plexus injury (47) Breast cancer screening (45) Breastfeeding challenges (106) Cerebral palsy (86) Cervical insufficiency (11) Contraception in a breastfeeding patient (116– 119) Delayed cord clamping (15) Enhanced recovery after surgery (68) Evaluation for thyroid disorders in pregnancy (72) Fetal death in a patient with a previous cesarean birth (74) Fetal growth restriction (62) Group B streptococci (139– 143) Hemolysis, elevated liver enzymes, and low platelet count syndrome (9) High risk for open neural tube defects and recommendation of dosing (22) Hypertension in pregnancy (38) Hyperthyroidism (46) Immunization in pregnancy (79) Induction in a patient undergoing a trial of labor after cesarean birth (34) Induction of labor (92) viii PROLOG Labor dystocia and indications for cesarean birth (148– 151) Low-dose aspirin for reduction of preeclampsia risk (18) Massive transfusion (97) Maternal cardiac arrest (49) Multifetal birth (50) Nausea and vomiting of pregnancy (103) Postpartum contraception (32) Postpartum mastitis (28) Preterm birth prevention (134– 138) Preterm labor (59) Prevention of recurrent preterm birth (76) Prophylaxis for a patient with potential exposure to human immunodeficiency virus (6) Seizure disorder medications (99) Severe rhesus disease in pregnancy (29) Testing for syphilis (3) Thrombocytopenia in pregnancy (129– 133) Thromboprophylaxis (101) Treatment of gestational diabetes mellitus (52) Use of corticosteroids in late preterm pregnancy (93) Vulvar lesions (53) Vulvovaginal hematoma management (41) Physiology Antiemetic drug metabolism (84) Obstetric changes in physiology (67) Prevention and Population Health COVID-19 pandemic population health effects (176– 179) Health disparities and health equity in obstetrics (193– 196) Influenza exposure (90) Intimate partner violence (205– 208) Vaccines in pregnancy (209– 213) Screening and Diagnosis Abnormal ultrasound findings (144– 147) Acute right-sided abdominal pain (54) Adnexal mass in pregnancy (100) Amniotic fluid (87) Aneuploidy screening (35) Antepartum fetal surveillance (189– 192) Antiphospholipid antibody syndrome (65) Apgar score (162– 166) Autoimmune disorders in pregnancy (98) Bell palsy (17) Cell-free DNA microdeletion detection (107) Dermatologic conditions in pregnancy (78) Diagnosis of congenital infection (12) Diagnosis of peripartum cardiomyopathy (23) Differential diagnosis for postpartum fever (80) Disseminated intravascular coagulation (105) Electronic fetal heart rate monitoring (214– 218) Evaluation of first-trimester bleeding (57) Fetal acid– base assessment (75) Fetal tachycardia (55) Gastric bypass surgery (39) Genetic carrier screening (108– 112) Gestational diabetes (31) Gram-positive bacteria in pregnancy (42) Headache in pregnancy (113– 115) Hepatitis B testing (152– 156) Hepatitis B treatment (26) Increased nuchal translucency measurement (20) Intra-amniotic infection (89) Intrapartum elec